Trusted Sources

NEVIRAPINE Questions ? Need a second opinion? Ask Our Health Experts!

Type your question here

 letters left

NEVIRAPINE Safety Reports

Total NEVIRAPINE reports: 154. NEVIRAPINE FDA safety alerts: 2004 2005 . Reported deaths: 46    Reported hospitalizations: 23. Read More Here.

< Previous  Showing 101-150 of 154 Next >

Physician from reported NEVIRAPINE problem on June 01, 2006. Female patient, weighting 55.12 lb, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome. NEVIRAPINE dosage: unknown. Patient was hospitalized and became disabled. Patient died on 06/03/2006.

NEVIRAPINE problem was reported by a Physician from on June 26, 2006. Female patient, child 6 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood creatine phosphokinase increased, mitochondrial toxicity, movement disorder. NEVIRAPINE dosage: unknown. During the same period patient was treated with ATACAVIR, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on June 28, 2006. Male patient, 56 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, bleeding varicose vein, hepatic failure, hepatic fibrosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on June 28, 2006. Male patient, 33 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatic fibrosis, portal vein thrombosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on June 28, 2006. Male patient, 28 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, liver disorder. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE, HYDROXYUREA. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on June 28, 2006. Male patient, 43 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, bleeding varicose vein, encephalopathy, hepatic failure, hepatic fibrosis, portal vein thrombosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE, HYDROXYUREA. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on June 28, 2006. Male patient, 27 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, liver disorder. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on June 28, 2006. Female patient, 45 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, hepatic failure, hepatic fibrosis, portal vein thrombosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on June 28, 2006. Male patient, 54 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, hepatic failure, hepatic fibrosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on June 28, 2006. Male patient, 37 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, bleeding varicose vein, hepatic failure, hepatic fibrosis, liver disorder, portal vein thrombosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on June 28, 2006. Male patient, 57 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, bleeding varicose vein, hepatic failure, hepatic fibrosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on June 28, 2006. Male patient, 36 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, hepatic failure, portal vein thrombosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on June 28, 2006. Male patient, 52 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, bleeding varicose vein, encephalopathy, hepatic failure, hepatic fibrosis, liver disorder, portal vein thrombosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE, HYDROXYUREA. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on June 28, 2006. Male patient, 51 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, liver disorder. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE, RITONAVIR. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on June 28, 2006. Male patient, 43 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: ascites, bleeding varicose vein, hepatic encephalopathy, hepatic failure, hepatic fibrosis, portal vein thrombosis. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE, HYDROXYUREA. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on June 01, 2006. Female patient was diagnosed with hiv infection, cryptococcosis, prophylaxis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection, cachexia, cryptococcosis, hepatotoxicity, mycobacterium avium complex infection, pneumonitis, rash. NEVIRAPINE dosage: 200 MG ONCE DAILY FOR 2 WEEKS, FOLLOWED BY 200 MG TWICE DAILY. During the same period patient was treated with FLUCONAZOLE. Patient died.

Consumer or non-health professional from reported NEVIRAPINE problem on July 05, 2006. Female patient was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hiv infection. NEVIRAPINE dosage: unknown. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on June 01, 2006. Female patient was diagnosed with hiv infection, cryptococcosis, prophylaxis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: mycobacterium avium complex infection. NEVIRAPINE dosage: 200 MG ONCE DAILY FOR 2 WEEKS, FOLLOWED BY 200 MG TWICE DAILY. During the same period patient was treated with FLUCONAZOLE. Patient died.

Consumer or non-health professional from reported NEVIRAPINE problem on June 01, 2006. Female patient was diagnosed with hiv infection and was treated with NEVIRAPINE. NEVIRAPINE dosage: 200 MG ONCE DAILY FOR 2 WEEKS, FOLLOWED BY 200 MG TWICE DAILY. Patient died.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on July 05, 2006. Female patient was diagnosed with prophylaxis, human immunodeficiency virus transmission and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hiv infection. NEVIRAPINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on June 28, 2006. Male patient, 28 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hepatic fibrosis, liver disorder, liver function test abnormal. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE, HYDROXYUREA. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on July 20, 2006. Female patient was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hiv infection. NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient died.

Consumer or non-health professional from reported NEVIRAPINE problem on July 20, 2006. Female patient was diagnosed with hiv infection, human immunodeficiency virus transmission, prophylaxis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased. NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient died.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Aug 04, 2006. Female patient was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: arthralgia, cholestasis, hepatotoxicity, hypersensitivity, ill-defined disorder, multi-organ disorder, myalgia, pyrexia. NEVIRAPINE dosage: unknown. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on Sept 21, 2005. Male patient was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: viral mutation identified. NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, TENOFOVIR. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Aug 07, 2006. Female patient was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: disease progression, hepatic fibrosis. NEVIRAPINE dosage: unknown. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on Aug 17, 2006. Female patient was diagnosed with prophylaxis against hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hiv infection. NEVIRAPINE dosage: unknown. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Mar 20, 2006. Male patient, 41 years of age, was diagnosed with retroviral infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: blood hiv rna increased, erythema, pruritus. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, STAVUDINE, KALETRA, LAMIVUDINE. Patient recovered.

Pharmacist from UNITED STATES reported NEVIRAPINE problem on Aug 23, 2006. Male patient, 39 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood bilirubin increased, cholelithiasis, hbv dna increased, hepatomegaly, murphy's sign positive. NEVIRAPINE dosage: 200MG - 2 TABS DAILY PO. During the same period patient was treated with EPIVIR, TENOFOVIR, MUPIROCIN, ZOLOFT, BACTRIM, ALBUTEROL. Patient was hospitalized. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Sept 15, 2005. Male patient, 58 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: asterixis, body temperature, coma, encephalitis, hepatic failure, hepatic necrosis, jaundice. NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, STAVUDINE, DIDANOSINE, INDINIVIR SULPHATE. Patient was hospitalized. Patient died.

Consumer or non-health professional from reported NEVIRAPINE problem on Aug 17, 2006. Male patient, 52 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, hepatitis b dna assay positive. NEVIRAPINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE, STAVUDINE, DIDANOSINE, NELFINAVIR. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Aug 17, 2006. Female patient, 47 years of age, was diagnosed with hiv infection, pneumonia and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, dyspnoea, hepatic failure, hepatic steatosis, lactic acidosis, obstructive airways disorder, pneumonia, pyrexia. NEVIRAPINE dosage: unknown. During the same period patient was treated with PARACETAMOL, STAVUDINE, DIDANOSINE, ANTIBIOTICS, BENZTROPINE MESYLATE, LOXAPINE, NSAID. Patient died.

Consumer or non-health professional from reported NEVIRAPINE problem on Aug 17, 2006. Female patient was diagnosed with hiv infection, human immunodeficiency virus transmission, prophylaxis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: human immunodeficiency virus transmission. NEVIRAPINE dosage: unknown. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Aug 17, 2006. Male patient was diagnosed with human immunodeficiency virus transmission, prophylaxis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hiv infection. NEVIRAPINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on Aug 17, 2006. Female patient was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: viral mutation identified. NEVIRAPINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE. Patient recovered.

NEVIRAPINE problem was reported by a Physician from on Aug 09, 2006. Female patient, 35 years of age, weighting 130.1 lb, was diagnosed with hiv infection, prophylaxis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: eyelid oedema, hepatotoxicity, pruritus, rash, skin toxicity. NEVIRAPINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on Aug 31, 2006. Male patient, 26 years of age, was diagnosed with hiv infection cdc category c3, meningitis cryptococcal, prophylaxis, antibiotic prophylaxis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: cryptococcosis, disease recurrence, immune reconstitution syndrome, lymphadenopathy, pain, sudden hearing loss. NEVIRAPINE dosage: unknown. During the same period patient was treated with FLUCONAZOLE, LAMIVUDINE, DIDANOSINE, TRIMETHOPRIM. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Sept 14, 2006. Male patient, 37 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: hepatitis b, hepatitis c antibody positive, hepatotoxicity, immune reconstitution syndrome. NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, STAVUDINE, NELFINAVIR. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on Sept 14, 2006. Male patient, 58 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: lipodystrophy acquired. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, LOPINAVIR. Patient recovered.

NEVIRAPINE problem was reported by a Physician from on Aug 09, 2006. Female patient, weighting 130.1 lb, was diagnosed with hiv infection, prophylaxis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: eyelid oedema, hepatotoxicity, pruritus, rash, skin toxicity. NEVIRAPINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NEVIRAPINE problem on Sept 21, 2006. Male patient, 67 years of age, weighting 200.8 lb, was diagnosed with acquired immunodeficiency syndrome, hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: asthenia, chills, diarrhoea, haemoptysis, hepatitis, incorrect dose administered, treatment noncompliance. NEVIRAPINE dosage: 200 MG PO BID. During the same period patient was treated with DOCUSATE, DIDANOSINE, LAMIVUDINE, CACLIUM ACETATE, CITRATE, EPOETIN ALFA, PRAVASTATIN. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Jan 05, 2007. Male patient, 41 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, jaundice, vanishing bile duct syndrome. NEVIRAPINE dosage: unknown. During the same period patient was treated with ABACAVIR, LAMIVUDINE. Patient recovered.

Physician from reported NEVIRAPINE problem on Jan 08, 2007. Female patient, weighting 5.29 lb, was diagnosed with prophylaxis against hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: human immunodeficiency virus transmission. NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Jan 09, 2007. Male patient, 47 years of age, was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatitis b. NEVIRAPINE dosage: unknown. During the same period patient was treated with ABACAVIR, TENOFOVIR. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on Jan 16, 2007. Male patient, 40 years of age, was diagnosed with hiv infection, pneumocystis jiroveci pneumonia and was treated with NEVIRAPINE. NEVIRAPINE dosage: unknown. During the same period patient was treated with LAMIVUDINE, STAVUDINE, CEFTRIOXONE, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ERYTHROMYCIN. Patient died on 03/28/2005.

NEVIRAPINE problem was reported by a Pharmacist from UNITED STATES on Feb 06, 2007. Male patient was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: stevens-johnson syndrome, toxic epidermal necrolysis. NEVIRAPINE dosage: 200 MG BID PO (DURATION: MONTHS). Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on Feb 07, 2007. Male patient, 32 years of age, was diagnosed with hiv infection, borderline leprosy, lepromatous leprosy and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: immune reconstitution syndrome, lepromatous leprosy. NEVIRAPINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, LAMIVUDINE, RIFAMPICIN, CLOFAZIMINE. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Feb 27, 2007. Female patient was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: caesarean section, hepatotoxicity, premature rupture of membranes. NEVIRAPINE dosage: 200 MG ONCE DAILY FOR 2 WEEKS, AFTER WHICH THE DOSE WAS ESCALATED TO 200 MG TWICE DAILY. Patient recovered.

Consumer or non-health professional from reported NEVIRAPINE problem on Feb 27, 2007. Female patient was diagnosed with hiv infection and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: caesarean section, foetal growth retardation, hellp syndrome. NEVIRAPINE dosage: 200 MG ONCE DAILY FOR 2 WEEKS, AFTER WHICH THE DOSE WAS ESCALATED TO 200 MG TWICE DAILY. Patient recovered.

NEVIRAPINE problem was reported by a Consumer or non-health professional from on Mar 13, 2007. Male patient, child 12 years of age, was diagnosed with hiv infection, cytomegalovirus oesophagitis and was treated with NEVIRAPINE. After drug was administered, patient experienced the following problems/side effects: cd4 lymphocytes decreased. NEVIRAPINE dosage: unknown. During the same period patient was treated with DIDANOSINE, TENOFOVIR DISOPROXIL FUMARATE, GANCICLOVIR, VALGANCICLOVIR. Patient was hospitalized. Patient recovered.

< Previous  Showing 101-150 of 154 Next >